|
Volumn 23, Issue 14, 2003, Pages
|
Overcoming challenges in biomanufacturing
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA1A INTERFERON;
ERYTHROPOIETIN;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
MONOCLONAL ANTIBODY;
RECOMBINANT ALPHA2B INTERFERON;
RECOMBINANT PROTEIN;
TUMOR NECROSIS FACTOR;
ARTICLE;
BIOTECHNOLOGY;
COST;
DRUG MANUFACTURE;
EUROPEAN UNION;
GOOD CLINICAL PRACTICE;
PROCESS DEVELOPMENT;
QUALITY CONTROL;
STANDARDIZATION;
HUMAN IMMUNODEFICIENCY VIRUS;
|
EID: 0042069934
PISSN: 02706377
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (0)
|